Sofinnova Ventures raises $650M for tenth fund

Sofinnova Ventures closed its largest fund to date, Sofinnova Venture Partners X, with $650 million.

The oversubscribed fund is to invest $15-$35 million in each of 20-25 companies, primarily in the U.S. but also in Europe. The firm said its fund will target mid-to-late stage companies, including those in the Orphan disease, oncology, women's health, dermatology, ophthalmology and infectious disease sectors. ...